In an unprecedented move, top AI CEOs are calling to slow the pace of artificial intelligence development, citing existential risks. But will they follow through? The recent proposal by Anthropic CEO Dario Amodei, titled “We Must Pace the Frontier,” has garnered support from OpenAI’s Sam Altman, Google DeepMind’s Demis Hassabis, and xAI’s Elon Musk. This rare consensus raises critical questions about the future of AI regulation and whether the industry will genuinely decelerate its rapid advancement.
The Call to Slow AI Development
Facing public uproar over warnings that AI could pose catastrophic risks, Anthropic’s Dario Amodei proposed slowing down AI development to ensure safety. The proposal includes embedding independent evaluators within companies to verify safety practices. In a surprising display of unity, other AI leaders quickly endorsed the idea. Sam Altman committed to matching Amodei’s pledge, stating, “I agree with Dario that we need to pace the frontier.” Demis Hassabis echoed support, and Elon Musk simply said, “Dario is right.”
Why AI CEOs Want to Pace the Frontier
The push to slow AI development stems from growing concerns about AI’s potential to cause harm, including existential threats. Anthropic researchers have repeatedly warned that AI could kill all of humanity by 2030 if not properly controlled. These warnings have fueled public fear and distrust, prompting lawmakers and industry leaders to consider regulatory measures. However, the hurdles to comprehensive AI regulation remain significant, including geopolitical competition and economic incentives.
Challenges to Slowing AI Development
Despite the CEOs’ public commitments, several obstacles could prevent meaningful slowdown. First, the race for AI supremacy among nations, particularly between the US and China, makes unilateral slowing risky. Second, shareholders and investors expect continuous innovation and growth. Third, the lack of enforceable international regulations means companies may face pressure to prioritize speed over safety. As a result, skepticism abounds about whether these promises will translate into action.
Comparison of AI CEO Commitments
| CEO | Company | Commitment |
|---|---|---|
| Dario Amodei | Anthropic | Proposed “We Must Pace the Frontier,” embedding independent evaluators |
| Sam Altman | OpenAI | Agreed to match commitment, will embed outside evaluators |
| Demis Hassabis | Google DeepMind | Supports Amodei’s essay as the right path forward |
| Elon Musk | xAI | Publicly endorsed Amodei’s stance |
Key Takeaways
- AI CEOs are publicly calling for slower development due to safety concerns.
- They propose independent evaluators to verify safety practices.
- Geopolitical and economic pressures may hinder actual slowdown.
- Regulatory efforts remain fragmented and challenging.
- Public trust in AI is at stake, and actions must follow words.
FAQ
Why do AI CEOs want to slow down AI development?
AI CEOs cite existential risks, including the potential for AI to cause catastrophic harm, and argue that slowing development allows for better safety measures and public trust.

Will AI companies actually slow down?
It’s uncertain. While CEOs have made public commitments, competitive pressures, investor expectations, and lack of regulation may prevent meaningful slowdown.
What is the “We Must Pace the Frontier” proposal?
Proposed by Dario Amodei, it suggests slowing AI advancement and embedding independent evaluators within AI companies to verify safety practices.
As AI continues to evolve, the tension between innovation and safety will only intensify. The CEOs’ pledges mark a significant moment, but only time will tell if they translate into real change.
Best Products We’ve Tested and Rated

Our testing team has hands-on reviews of stair climber machine, elliptical trainer, rowing machine, gummies nerve pain, and coffee creamer diabetics. Every option below was compared across price, build quality, and real-world performance, with honest pros and cons. We update these guides regularly as new models arrive, so the recommendations stay current.
Our testing team has hands-on reviews of tanning lotion, castor oil knee pain, tirzepatide compounding pharmacy, chewing gum, and morning tea. Every option below was compared across price, build quality, and real-world performance, with honest pros and cons. We update these guides regularly as new models arrive, so the recommendations stay current.